| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in diagnosis, classification, and management of pain in Parkinson's disease
|
Tinazzi, Michele
|
|
|
24 |
4 |
p. 331-347
|
artikel
|
| 2 |
Advancing policies for rare diseases in Europe
|
The Lancet Neurology,
|
|
|
24 |
4 |
p. 275
|
artikel
|
| 3 |
Advocating for increased awareness and research on Down syndrome
|
Potier, Marie-Claude
|
|
|
24 |
4 |
p. 288
|
artikel
|
| 4 |
Amyloid immunotherapy to prevent Alzheimer's disease: the wrong drug at the right time?
|
Schott, Jonathan M
|
|
|
24 |
4 |
p. 279-281
|
artikel
|
| 5 |
An operational measurement of brain health: the ABCDS framework
|
Avan, Abolfazl
|
|
|
24 |
4 |
p. 291-292
|
artikel
|
| 6 |
Augusta Dejerine-Klumpke, a neurologist ahead of her time
|
Drouin, Emmanuel
|
|
|
24 |
4 |
p. 290
|
artikel
|
| 7 |
Consciousness contextualised
|
Stirrups, Robert
|
|
|
24 |
4 |
p. 293
|
artikel
|
| 8 |
Epilepsy with myoclonic-atonic seizures: an update on genetic causes, nosological limits, and treatment strategies
|
Guerrini, Renzo
|
|
|
24 |
4 |
p. 348-360
|
artikel
|
| 9 |
Gianfranco De Stefano
|
|
|
|
24 |
4 |
p. 290
|
artikel
|
| 10 |
Intravenous thrombolysis before endovascular treatment versus endovascular treatment alone for patients with large vessel occlusion and carotid tandem lesions: individual participant data meta-analysis of six randomised trials
|
Cavalcante, Fabiano
|
|
|
24 |
4 |
p. 305-315
|
artikel
|
| 11 |
Multiple sclerosis and COVID-19: interactions and unresolved issues
|
Zabalza, Ana
|
|
|
24 |
4 |
p. 361-370
|
artikel
|
| 12 |
Paediatric neurology in Ukraine: a call for help
|
Nechai, Alla
|
|
|
24 |
4 |
p. 287-288
|
artikel
|
| 13 |
Pharmacological therapy for cerebral cavernous malformations
|
Salman, Rustam Al-Shahi
|
|
|
24 |
4 |
p. 276-277
|
artikel
|
| 14 |
Raising awareness of degenerative cervical myelopathy
|
Wardropper, Jay John
|
|
|
24 |
4 |
p. 286-287
|
artikel
|
| 15 |
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial
|
Awad, Issam A
|
|
|
24 |
4 |
p. 295-304
|
artikel
|
| 16 |
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
|
Bateman, Randall J
|
|
|
24 |
4 |
p. 316-330
|
artikel
|
| 17 |
SARS-CoV-2 infection in people with multiple sclerosis
|
Fitzgerald, Kathryn C
|
|
|
24 |
4 |
p. 281-282
|
artikel
|
| 18 |
The artist and the scientist join forces for rare diseases
|
Morgan, Jules
|
|
|
24 |
4 |
p. 294
|
artikel
|
| 19 |
The Genetic Epidemiology of Parkinson's Disease view
|
Farrer, Matthew J
|
|
|
24 |
4 |
p. 285
|
artikel
|
| 20 |
The Genetic Epidemiology of Parkinson's Disease view – Authors' reply
|
Lim, Shen-Yang
|
|
|
24 |
4 |
p. 285-286
|
artikel
|
| 21 |
Thrombolysis before endovascular treatment of tandem lesions
|
Lapergue, Bertrand
|
|
|
24 |
4 |
p. 277-279
|
artikel
|
| 22 |
Tom Solomon: world records, academic leadership, and emerging infections
|
Morgan, Jules
|
|
|
24 |
4 |
p. 289
|
artikel
|
| 23 |
Uncontrolled CAG expansion in neurons susceptible to Huntington's disease
|
Durr, Alexandra
|
|
|
24 |
4 |
p. 282-284
|
artikel
|
Tijdschrift beschrijving